Old Web
English
Sign In
Acemap
>
authorDetail
>
N Candela
N Candela
Takeda Pharmaceutical Company
Medicine
Vedolizumab
Internal medicine
Ulcerative colitis
in patient
7
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P472 Payer addressable burden of Crohn’s disease in patients treated with ustekinumab and vedolizumab in the United States
2021
Journal of Crohn's and Colitis
T Ghosh
I. Smith
J Fehr
J Davidson
T Fan
N Candela
C Tsang
T Koch
Show All
Source
Cite
Save
Citations (0)
P326 An exploratory analysis of the impact of COVID-19 on colonoscopy procedures and new biologic treatment initiation among patients with Inflammatory Bowel Disease in the United States
2021
Journal of Crohns & Colitis
Ryan C. Ungaro
B Chou
J Mo
L Ursos
R Twardowski
N Candela
Jean-Frederic Colombel
Show All
Source
Cite
Save
Citations (0)
P805 Patients with Crohn’s disease treated with ustekinumab vs. vedolizumab in real-world settings
2020
Journal of Crohns & Colitis
Michael V. Chiorean
J Jiang
N Candela
G Chen
H Romdhani
Dominick Latremouille-Viau
Sherry Shi
R Bungay
T Fan
Show All
Source
Cite
Save
Citations (0)
P510 Dose escalation of subcutaneous vedolizumab in patients with ulcerative colitis: A post hoc analysis of the VISIBLE trial data
2020
Journal of Crohns & Colitis
William J. Sandborn
Douglas C. Wolf
G D’Haens
Johan P. Jansson
J Chen
Sharif M. Uddin
N Candela
Karen Lasch
K Kisfalvi
Show All
Source
Cite
Save
Citations (0)
1